High serum levels of vascular endothelial growth factor-C have a positive impact on outcome of patients with advanced diffuse large B cell lymphoma
Explore this paper's citation graph
Summary
1 Á rea de Oncohematolog í a, Hospital Costa del Sol, Marbella, Spain, 2 IBIMA, Instituto de Investigaci ó n Biomedica de M á laga,Spain, 3 REDISSEC, Red de Investigac n en Servicios Sanitarios en Enfermedades Cr ó nicas.
- Type
- letter
- Published
- 2014-06-01
- Cited by
- 5
- References
- 18
- Access
- Open access
- OpenAlex
- https://openalex.org/W2133285042
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:2754818
Keywords
Lymphoma, Medicine, Diffuse large B-cell lymphoma, Vascular endothelial growth factor, Internal medicine
References
- Expression of VEGF-C, VEGF-D and their receptor VEGFR-3 in diffuse large B-cell lymphomas
- Angiogenesis and antiangiogenesis.
- Molecular regulation of angiogenesis and lymphangiogenesis
- The prognostic significance of VEGF-C and VEGF-A in non-Hodgkin lymphomas
- Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP)
- The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients
- Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: A report from the International DLBCL Rituximab-CHOP Consortium Program Study
- R‐CHOP‐14 in patients with diffuse large B‐cell lymphoma younger than 70 years: a multicentre, prospective study
- High serum vascular endothelial growth factor level is an adverse prognostic factor for high‐risk diffuse large B‐cell lymphoma patients treated with dose‐dense chemoimmunotherapy
- R-CHOP-14 in patients with diffuse large B-cell lymphoma: Feasibility and preliminary efficacy
- Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.
- Double-hit diffuse large B-cell lymphoma.
- Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
- Proteolytic processing regulates receptor specificity and activity of VEGF‐C
- A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma.
- The Addition of Bevacizumab to Standard Therapy with R-CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma Is Associated with an Increased Rate of Cardiac Adverse Events: Final Analysis of Safety and Efficacy Outcomes From the Placebo-Controlled Phase 3 MAIN Study
Cited by
- Correlation between serum levels of vascular endothelial growth factor-C and sentinel lymph node status in early breast cancer
- Role of vascular endothelial growth factor C in classical Hodgkin lymphoma
- Serum vascular endothelial growth factor A levels reflect itch severity in mycosis fungoides and Sézary syndrome
- High serum vascular endothelial growth factor C predicts better relapse-free survival in early clinically node-negative breast cancer
- B-cell non-Hodgkin lymphoma: importance of angiogenesis and antiangiogenic therapy
Related papers
- Different prevalence and clinical outcome of Epstein-Barr virus positive diffuse large B-cell lymphoma between North American and non-Western populations.
- Expression of total vascular endothelial growth factor (VEGF) and inhibitory isoforms of VEGF in head and neck squamous cell carcinoma
- Serum vascular endothelial growth factor (VEGF), soluble VEGF receptor-1 (sVEGFR-1) and sVEGFR-2 in systemic sclerosis patients: Relation to clinical manifestations and capillaroscopy findings
- The Effect of VEGF (Vascular endothelial growth factor) on Endothelial Cells in Pathogenesis of Preeclampsia
- The effect of AD-VEGF-siRNA on the expression of vascular endothelial growth factor in osteosarcoma-bearing nude mice
- 322 ESTROGENS STIMULATE THE GROWTH OF HUMAN CHOLANGIOCARCINOMA BY ACTIVATING THE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) SYSTEM
- Vascular Endothelial Growth Factor (VEGF) In Aqueous Humor: Prognostic Factor In Uveal Melanoma